tiprankstipranks
Biocept (BIOCQ)
OTHER OTC:BIOCQ
Holding BIOCQ?
Track your performance easily

Biocept (BIOCQ) Income Statement

1,250 Followers

Biocept Income Statement

Last quarter (Q2 2023), Biocept's total revenue was $589.00K, a decrease of -89.88% from the same quarter last year. In Q2, Biocept's net income was $-3.63M. See Biocept’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 1.36M$ 25.86M$ 61.25M$ 27.46M$ 5.53M$ 3.25M
Cost of Revenue
$ 15.66M$ 28.44M$ 37.76M$ 21.34M$ -10.98M$ -10.05M
Gross Profit
$ -19.04M$ -2.58M$ 23.48M$ 6.12M$ -5.45M$ -6.80M
Operating Expense
$ 2.53M$ 29.40M$ 63.70M$ 21.57M$ 17.61M$ 17.46M
Operating Income
$ -37.39M$ -31.98M$ -2.41M$ -15.47M$ -23.06M$ -24.26M
Net Non Operating Interest Income Expense
$ -293.00K$ -316.00K$ -290.00K$ -236.00K$ -2.08M$ -310.98K
Other Income Expense
$ -2.77M$ 87.00K-$ 2.10M--
Pretax Income
$ -34.97M$ -32.21M$ -2.70M$ -17.81M$ -25.14M$ -24.57M
Tax Provision
$ -125.00K$ -125.00K$ 125.00K$ -940.00K-$ 1.89K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -30.61M$ -32.09M$ -2.82M$ -17.81M$ -25.26M$ -25.21M
Basic EPS
$ -16.99$ -1.89$ -5.70$ -45.00$ -36.60$ -270.30
Diluted EPS
$ -16.99$ -1.89$ -5.70$ -45.00$ -36.60$ -270.30
Basic Average Shares
$ 35.68M$ 16.95M$ 492.53K$ 394.84K$ 688.70K$ 93.27K
Diluted Average Shares
$ 35.68M$ 16.95M$ 492.53K$ 394.84K$ 688.70K$ 93.27K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 52.59M$ 57.84M$ 101.46M$ 42.91M$ 6.63M$ 7.41M
Net Income From Continuing And Discontinued Operation
$ -34.82M$ -32.09M$ -2.82M$ -17.81M$ -25.14M$ -24.57M
Normalized Income
$ -2.87M-----
Interest Expense
------
EBIT
$ -34.51M$ -31.90M$ -2.41M$ -17.57M$ -24.89M$ -24.26M
EBITDA
$ -32.64M$ -30.24M$ -879.00K$ -16.57M$ -24.11M$ -23.46M
Currency in USD

Biocept Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis